Abstract:Background Periprocedural bleeding complications remain a significant issue in patients undergoing percutaneous coronary intervention (PCI). Although most bleeding complications are defined by the degree of haemoglobin drop, prognostic implications of haemoglobin drop without clinically overt bleeding remain unclear. Purpose We aimed to investigate the association between haemoglobin drop after PCI and long-term prognosis, stratified by the occurrence of clinically overt bleeding. Methods Consecutive patients discharged after PCI between September 2008 to June 2018 from Keio Cardiovascular PCI multicenter prospective registry in Japan were analyzed. Patients were categorized into four groups: those with overt bleeding with haemoglobin drop, those with overt bleeding without haemoglobin drop, those without overt bleeding with haemoglobin drop, and those without overt bleeding nor haemoglobin drop. The pre- and post-PCI haemoglobin were defined as the lowest value within 72 hours before and after PCI. We defined the haemoglobin drop as the value obtained by subtracting the pre-PCI haemoglobin value from the post-PCI haemoglobin value equal to or greater than 3.0 g/dL. The primary outcome was the 2-year composite of major adverse cardiovascular events (MACE): all-cause mortality, acute coronary syndrome, heart failure hospitalization, or stroke. Cox proportional models were used to assess the association between the haemoglobin drop and the clinical outcomes. Results Among the 6,013 patients [mean age 68 years and 78% male], 52 (0.9%) had overt bleeding with haemoglobin drop, 45 (0.7%) had overt bleeding without haemoglobin drop, 497 (8.3%) had haemoglobin drop without overt bleeding, and 5,419 (90.1%) had neither. At the two-year follow-up, patients with overt bleeding, both with and without haemoglobin drop had higher rates of MACE compared to those without overt bleeding, with and without haemoglobin drop (28.8% vs. 20.0% vs. 11.8% vs. 10.5%, respectively). Patients with overt bleeding with haemoglobin drop were associated with increased risks of MACE compare to those without overt bleeding without haemoglobin drop (HR: 2.19, 95% CI: 1.26-3.81, P=0.01). Conversely, patients without overt bleeding with haemoglobin drop and patients with overt bleeding without haemoglobin drop were not associated with increased risk of MACE (HR:1.19, 95% CI: 0.88-1.63, P=0.26, and HR: 0.62, 95% CI: 0.29-1.31, P=0.21, respectively). The spline curve showed a significant correlation between haemoglobin drop and MACE in patients with overt bleeding. However, for patients without overt bleeding, the correlation was attenuated. Conclusions Patients with haemoglobin drop with overt bleeding were significantly associated with long-term prognosis, but no association was observed among those with haemoglobin drop without overt bleeding. Our findings prompt a reevaluation of the current criteria for classifying bleeding complications.Figure

Association of Hemoglobin Levels with Long-Term Mortality in Male Patients Undergoing Percutaneous Coronary Interventions

Effects of Hemoglobin Levels on Long-Term Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Hemoglobin A1c Levels Affect Visit-to-visit Variability of Lipid Profiles in Patients Undergoing Elective Percutaneous Coronary Intervention: A Retrospective Study

[Long-Term Outcomes and Risk Factors of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery after Percutaneous Coronary Intervention].

Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

Anemia As an Independent Predictor of Poor Long-Term Outcomes after Percutaneous Coronary Intervention

Gender Differences and Other Risk Factors in Long-Term Mortality for Patients after Percutaneous Coronary Intervention

Long-term Outcome Comparison of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery Treated by PCI or CABG

Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis

The Impact of Red Blood Cell Distribution Width on Outcome of Elective Percutaneous Coronary Intervention in Non-Anemia Patients

[Effects of Chronic Renal Insufficiency and Anemia Upon Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention].

Association between haemoglobin decline and long-term outcomes in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention

Red Blood Cell Distribution Width and Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stenting Era: a Two-Year Cohort Study.

Gender Differences in Mortality after Percutaneous Coronary Intervention

Relationship Between Red Blood Cell Distribution Width and Intermediate-Term Mortality in Elderly Patients after Percutaneous Coronary Intervention.

Prognostic value of hemoglobin level and CAMI-STEMI score in patients with acute ST segment elevation myocardial infarction after PCI

Association between in-hospital haemoglobin drop with or without overt bleeding and long-term clinical outcomes after percutaneous coronary intervention

Long-term Outcome Analysis of Patients Underwent Percutaneous Coronary Intervention with Prior Ischemic Stroke

Predictors of Mortality in Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention

Association of Hemoglobin Glycation Index with Prognosis of Coronary Artery Disease after Percutaneous Coronary Intervention: A Retrospective Cohort Study.

Risk Stratification Algorithm for Clinical Outcomes in Anemic Patients Undergoing Percutaneous Coronary Intervention.